Literature DB >> 31359959

Clinical Mimickers of Amyotrophic Lateral Sclerosis-Conditions we Cannot Afford to Miss.

Nishita Singh1, Sucharita Ray1, Achal Srivastava1.   

Abstract

Entities:  

Year:  2019        PMID: 31359959      PMCID: PMC6613410          DOI: 10.4103/aian.AIAN_456_18

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
Sir, We thank you for the appreciation of out paper “Clinical mimickers of amyotrophic lateral sclerosis-conditions we cannot afford to miss.” In this discussion, you have managed to bring our two very interesting entities which can mimic an anterior horn cell pathology. Lyme disease presenting as multiple radiculopathy is a very challenging but rewarding diagnosis to make in patients with rapidly progressive weakness involving cranial nerves and/or peripheral nerves, with or without cord involvement. I think the presence of a rash and pain as two initial symptoms can be a good clue to the detection of this treatable condition. It was also interesting to note the role of eosinophilic fasciitis, but during active disease, the local symptoms can clearly demarcate the lesion. However, residual contracture can be a confounding factor in patients with healed eosinophilic fasciitis and this condition can be kept as a differential of anterior horn cell localization.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  2 in total

1.  Novel Genetic Signatures Associated With Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Robert Logan; Juleah Dubel-Haag; Nicolas Schcolnicov; Sean J Miller
Journal:  Front Genet       Date:  2022-03-24       Impact factor: 4.599

2.  Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: the 'split-leg' sign.

Authors:  Young Gi Min; Seok-Jin Choi; Yoon-Ho Hong; Sung-Min Kim; Je-Young Shin; Jung-Joon Sung
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.